Cochleovestibular Transient Ischemic Attack as a Manifestation of Patent Foramen Ovale.

Ischemic Stroke in Patients with Percutaneous Patent Foramen Ovale Closure

Background: The prevalence of patent foramen ovale is approximately 50% in patients who have suffered a cryptogenic stroke. The recurrence of ischemic stroke after percutaneous patent foramen ovale closure is approximately 1% per year. Objective: The aim of this study was to evaluate the prevalence of recurrent ischemic stroke in our population undergoing percutaneous patent foramen ovale closu...

Patent foramen ovale and cryptogenic stroke: the hole story.

Despite 3 recent randomized clinical trials, the management of patients with cryptogenic stroke and patent foramen ovale remains unsettled. The primary results of Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale (CLOSURE), Percutaneous Closure of Patent Foramen Ovale in...

Use of the transseptal puncture in transcatheter closure of long tunnel-type patent foramen ovale.

Two patients with long tunnel-type patent foramen ovale presented for elective transcatheter closure following transient ischaemic attack and stroke. Right to left shunting was confirmed on transthoracic and transoesophageal echocardiography. A new technique that used a transseptal procedure was devised to enable closure of the tunnel-type patent foramen ovale using the CardioSEAL transseptal o...

Should percutaneous devices be used to close a patent foramen ovale after cerebral infarction or TIA?

Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: A randomized clinical trial

BACKGROUND This randomized clinical trial compared rates of stroke or transient ischemic attack recurrence or death in patients with cryptogenic stroke and patent foramen ovale (PFO) who received medical treatment with aspirin or warfarin. MATERIALS AND METHODS Forty-four Iranian patients with cryptogenic stroke and patent foramen ovale participated in this randomized, single-blind trial betw...